DCAL — Dishman Carbogen Amcis Share News
0.000.00%
Last trade - 00:00- IN₹21.37bn
- IN₹41.82bn
- IN₹29.32bn
India's Dishman Carbogen Amcis falls after posting quarterly loss
Brief: Dishman Carbogen Amcis June-Quarter Consol Net Loss 578.8 Million Rupees
Brief: Dishman Carbogen Amcis Says Unit Successfully Completed GMP Inspection By China's NMPA For Shanghai Site
Brief: Dishman Carbogen Amcis Ltd Approves Issue Of Up To 1 Billion Rupees NCDs On Private Placement Basis
India's Dishman Carbogen Amcis drops after posting quarterly loss
Brief: Dishman Carbogen Amcis Dec-Quarter Consol Net Loss After Tax 129.7 Million Rupees
Brief: Dishman Carbogen Amcis To Consider Fund Raising Via NCDs
Brief: Dishman Carbogen Amcis Receives EIR From US FDA Indicating Inspection Closure
Brief: Dishman Carbogen Amcis Says Subsidiary Awarded Drug Manufacturing License From Chinese NMPA
Brief: Dishman Carbogen Amcis Says Unit Receives Drug Manufacturing License From NMPA For Shanghai Site
Brief: Dishman Carbogen Amcis's unit Gets GMP Compliance Certificate For Saint-Beauzire Site
India's Dishman Carbogen gains after nod to raise 500 mln rupees
Brief: Dishman Carbogen Amcis Approves Issue Of Debentures Up To 500 Million Rupees
Brief: Dishman Carbogen Amcis To Consider And Approve Proposal Of Fund Raising
Brief: Dishman Carbogen Amcis Dec-Quarter Consol Net Profit 46.3 Million Rupees
Brief: Dishman Carbogen Amcis Unit Successfully Completes Swissmedic Inspection Of Vionnaz Facility
India's Dishman Carbogen surges on posting Q2 profit
India's Dishman Carbogen up after clean chit from US FDA
Brief: Dishman Carbogen Amcis Says Unit Completed Us FDA Inspection Of Manufacturing Sites Located In Hunzenschwil And Aarau, In Switzerland